COVID-19 (coronavirus): Long-term effects

COVID-19 (coronavirus): Long-term effects

COVID-19 symptoms can sometimes persist for months. The virus can damage the lungs, heart and brain, which increases the risk of long-term health problems.

By Mayo Clinic Staff

Most people who have coronavirus disease 2019 (COVID-19) recover completely within a few weeks. But some people — even those who had mild versions of the disease — continue to experience symptoms after their initial recovery.

These people sometimes describe themselves as “long haulers” and the conditions have been called post-COVID-19 syndrome or “long COVID-19.” These health issues are sometimes called post-COVID-19 conditions. They’re generally considered to be effects of COVID-19 that persist for more than four weeks after you’ve been diagnosed with the COVID-19 virus.

Older people and people with many serious medical conditions are the most likely to experience lingering COVID-19 symptoms, but even young, otherwise healthy people can feel unwell for weeks to months after infection. Common signs and symptoms that linger over time include:

  • Fatigue
  • Shortness of breath or difficulty breathing
  • Cough
  • Joint pain
  • Chest pain
  • Memory, concentration or sleep problems
  • Muscle pain or headache
  • Fast or pounding heartbeat
  • Loss of smell or taste
  • Depression or anxiety
  • Fever
  • Dizziness when you stand
  • Worsened symptoms after physical or mental activities

Video: Long-term symptoms, complications of COVID-19

Organ damage caused by COVID-19

Although COVID-19 is seen as a disease that primarily affects the lungs, it can damage many other organs as well. This organ damage may increase the risk of long-term health problems. Organs that may be affected by COVID-19 include:

  • Heart. Imaging tests taken months after recovery from COVID-19 have shown lasting damage to the heart muscle, even in people who experienced only mild COVID-19 symptoms. This may increase the risk of heart failure or other heart complications in the future.
  • Lungs. The type of pneumonia often associated with COVID-19 can cause long-standing damage to the tiny air sacs (alveoli) in the lungs. The resulting scar tissue can lead to long-term breathing problems.
  • Brain. Even in young people, COVID-19 can cause strokes, seizures and Guillain-Barre syndrome — a condition that causes temporary paralysis. COVID-19 may also increase the risk of developing Parkinson’s disease and Alzheimer’s disease.

Some adults and children experience multisystem inflammatory syndrome after they have had COVID-19. In this condition, some organs and tissues become severely inflamed.


Get the latest health advice from Mayo Clinic delivered to your inbox.

Sign up for free, and stay up-to-date on research advancements, health tips and current health topics, like COVID-19, plus expert advice on managing your health.

Get more in-depth expert advice.

Sign up for special offers on Mayo Clinic books, products and services, designed by experts to help people manage their health

To provide you with the most relevant and helpful information and to understand which information is beneficial, we may combine your e-mail and website usage information with other information we have about you. If you are a Mayo Clinic Patient, this could include Protected Health Information (PHI). If we combine this information with your PHI, we will treat all of that information as PHI, and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of e-mail communications at any time by clicking on the Unsubscribe link in the e-mail.

Thank you for Subscribing

Our Housecall e-newsletter will keep you up-to-date on the latest health information.

We’re sorry! Our system isn’t working. Please try again.

Something went wrong on our side, please try again.

Blood clots and blood vessel problems

COVID-19 can make blood cells more likely to clump up and form clots. While large clots can cause heart attacks and strokes, much of the heart damage caused by COVID-19 is believed to stem from very small clots that block tiny blood vessels (capillaries) in the heart muscle.

Other parts of the body affected by blood clots include the lungs, legs, liver and kidneys. COVID-19 can also weaken blood vessels and cause them to leak, which contributes to potentially long-lasting problems with the liver and kidneys.

Problems with mood and fatigue

People who have severe symptoms of COVID-19 often have to be treated in a hospital’s intensive care unit, with mechanical assistance such as ventilators to breathe. Simply surviving this experience can make a person more likely to later develop post-traumatic stress syndrome, depression and anxiety.

Because it’s difficult to predict long-term outcomes from the new COVID-19 virus, scientists are looking at the long-term effects seen in related viruses, such as the virus that causes severe acute respiratory syndrome (SARS).

Many people who have recovered from SARS have gone on to develop chronic fatigue syndrome, a complex disorder characterized by extreme fatigue that worsens with physical or mental activity, but doesn’t improve with rest. The same may be true for people who have had COVID-19.

Many long-term COVID-19 effects still unknown

Much is still unknown about how COVID-19 will affect people over time, but research is ongoing. Researchers recommend that doctors closely monitor people who have had COVID-19 to see how their organs are functioning after recovery.

Many large medical centers are opening specialized clinics to provide care for people who have persistent symptoms or related illnesses after they recover from COVID-19. Support groups are available as well.

It’s important to remember that most people who have COVID-19 recover quickly. But the potentially long-lasting problems from COVID-19 make it even more important to reduce the spread of COVID-19 by following precautions. Precautions include wearing masks, social distancing, avoiding crowds, getting a vaccine when available and keeping hands clean.

May 06, 2021

  1. Carfi A, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; doi:10.1001/jama.2020.12603.
  2. Teneforde MW, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March-June 2020. MMWR Morbidity and Mortality Weekly Report. 2020; doi: 10.15585/mmwr.mm6930e1.
  3. McIntosh K. Coronavirus disease 2019 (COVID-19): Clinical features. Accessed July 23, 2020.
  4. Puntman VO, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020; doi:10.1001/jamacardio.2020.3557.
  5. Yancy CW, et al. Coronavirus disease 2019 (COVID-19) and the heart — Is heart failure the next chapter? JAMA Cardiology. 2020; doi:10.1001/jamacardio.2020.3575.
  6. Mitrani RD, et al. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020; doi:10.1016/j.hrthm.2020.06.026.
  7. Salehi S, et al. Long-term pulmonary consequences of coronavirus disease 2019 (COVID-19): What we know and what to expect. Thoracic Imaging. 2020; doi:10.1097/RTI.0000000000000534.
  8. Fotuhi M, et al. Neurobiology of COVD-19. Journal of Alzheimer’s Disease. 2020; doi:10.3233/JAD-200581.
  9. Pero A, et al. COVID-19: A perspective from clinical neurology and neuroscience. The Neuroscientist. 2020; doi:10.1177/1073858420946749.
  10. Myalgic encephalomyelitis/chronic fatigue syndrome: Information for healthcare providers. Centers for Disease Control and Prevention. Accessed Feb. 4, 2020.
  11. Barker-Davies RM, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. British Journal of Sports Medicine. 2020; doi:10.1136/bjsports-2020-102596.
  12. Lambert NJ, et al. COVID-19 “long hauler” symptoms survey report. Survivor Corps. . Accessed Nov. 13, 2020.
  13. Living with COVID-19: A dynamic review of the evidence around ongoing COVID-19 symptoms (often called long COVID). National Institute for Health Research. Accessed Nov. 10, 2020.
  14. Levison ME. Commentary: What we know so far about post-COVID syndrome. Merck Manual Professional Version. Accessed Nov. 13, 2020.
  15. Post-COVID-19 conditions. Centers for Disease Control and Prevention. Accessed April 9, 2020.
  16. Post-COVID conditions: Information for healthcare providers. Centers for Disease Control and Prevention. Accessed April 9, 2020.

See more In-depth

Products and Services

  1. U.S. COVID-19 Vaccine Tracker: See your state’s progress
  2. Coronavirus map: Tracking the trends


Leave a Comment

Your email address will not be published. Required fields are marked *

Translate »